The manzamines as an example of the unique structural classes available for the discovery and optimization of infectious disease controls based on marine natural products

Current Pharmaceutical Design

Volumn 13, Issue 6, 2007, Pages 653-660

  Hamann, Mark T ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Infectious diseases; Malaria; Manzamine; Marine natural products

Indexed keywords

ALKALOID; AMODIAQUINE; ANTIFUNGAL AGENT; ANTIMALARIAL AGENT; ANTINEMATODAL AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; ARTEMISININ; ARTESUNATE; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; CHLORPROGUANIL PLUS DAPSONE; FANSIDAR; HALOFANTRINE; INDOLE ALKALOID; MANZAMINE DERIVATIVE; MEFLOQUINE; NATURAL PRODUCT; PATELLAMIDE A; PATELLAMIDE C; PATELLAMIDE DERIVATIVE; PIPERAQUINE; PRIMAQUINE; PROGUANIL; PYRONARIDINE; QUININE; RIFAMPICIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

COMBINATION CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; DRUG CLASSIFICATION; DRUG HALF LIFE; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG RESEARCH; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; INFECTION CONTROL; MALARIA; MULTIDRUG RESISTANCE; NONHUMAN; PARASITOSIS; PHARMACOPHORE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PRODUCT DEVELOPMENT; REVIEW; SEA; TUBERCULOSIS;

ANIMALS; BIOLOGICAL PRODUCTS; COMMUNICABLE DISEASES; HUMANS; INDOLE ALKALOIDS; MARINE BIOLOGY;

EID: 33947599966     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207780162818     Document Type: Review

References (51)

1. Mayer AMS, Hamann MT. Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, antihelmintic, antiinflammatory, antiplatelet, antiprotozoal and antiviral activities; affecting the cardiovascular, endocrine, immune and nervous systems and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol 2002, 132C: 315-39.
2. Mayer AMS, Hamann MT. Marine pharmacology in 2000: compounds with antibacterial, anticoagulant, antifungal, antihelmintic, antiinflammatory, antiplatelet, antiprotozoal and antiviral activities; affecting the cardiovascular, endocrine, immune and nervous systems and other miscellaneous mechanisms of action. Mar Biotechnol 2004; 6: 37-52.
3. Mayer AMS, Hamann MT. Marine pharmacology in 2001-2002: compounds with antihelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, antiinflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis and antiviral activities; affecting the cardiovascular, endocrine, immune and nervous systems and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol 2005; 140: 265-86.
4. Kayser O, Kiderlen AF, Croft SL. Natural products as potential antiparasitic drugs. Atta-ur-Rahman Ed., Studies in Natural Products Chemistry (Bioactive Natural Products, Part G) Elsevier Science, Amsterdam, The Netherlands 2002; 26: 779-48.
5. Ghisalberti EL. Secondary metabolites with antinematodal activity. In: Atta-ur-Rahman Ed., Studies in Natural Products Chemistry (Bioactive Natural Products, Part G) Elsevier Science, Amsterdam, The Netherlands 2002; 26: 425-506.
6. El Sayed KA, Bartyzel P, Shen X, Perry TL, Zjawiony JK, Hamann MT. Marine natural products as antituberculosis agents. Tetrahedron 2000; 56: 949-53.
7. Hong-yu L, Matsunaga S, Fusetani N. Antifungal metabolites from marine sponges, Curr Org Chem 1998; 2: 649-82.
8. Newman DJ, Cragg GM, Snader KM. The influence of natural products upon drug discovery. Nat Prod Rep 2000; 17: 215-34.
9. Faulkner DJ. Marine natural products. Nat Prod Rep 2002; 19: 1-48.
10. Gul W, Hamann MT. Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases. Life Sci 2005; 78: 442-53.
11. Kremsner FG, Krishna S. Antimalarial combinations. Lancet 2004; 364: 285-94.
12. Honigsbaum M. The fever trail: in search for the cure for malaria. Farrar, Straus and Giroux 2001; 1-307.
13. Bradner WT. In: Cancer and chemotherapy. Vol. 1, Crooke ST, Prestayko AW, Eds., New York, Academic Press. 1980; 313.
14. Donia M, Hamann MT. Marine natural products and their potential applications as antiinfective agents. Lancet Infect Dis 2003; 3: 338-48.
15. Blunt JW, Munro MHG. Marinlit: a database of the literature on marine natural products. University of Canterbury 2005.
16. Adjuik M, Agnamey P, Babiker A, Baptista J, Borrmann S, Brasseur P et al. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 2004; 363: 9-17.
17. Enticknap JJ, Thompson R, Peraud O, Lohr JE, Hamann MT, Hill RT. Molecular analysis of a Florida Keys sponge: implications for natural products discovery. Mar Biotechnol 2004; 6: 288-93.
18. Schmidt EW, Nelson JT, Rasko DA, Sudek S, Eisen JA, Haygood MG, et al. Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemnin, the cyanobacterial symbiont of Lissoclinum patella. Proc Natl Acad Sci USA 2005; 102(20): 7315-20.
19. a) Petsko GA. For medicinal purposes. Nature 1996; 384(6604): 7-10;
20. b) Verdine GL. The combinatonal chemistry of nature. Nature 1996; 384(6604): 11-13.
21. Nicolaou KC, Sanghee K, Pfefferkorn J, Xu J, Ohshima T, Hosokawa S, et al. Synthesis and biological activity of sarcodictyins. Angew Chem Int Edit 1998; 37: 1418-21.
22. Tan DS, Foley MA, Shair MD, Schreiber SL. Stereoselective synthesis of over two million compounds having structural features both reminiscent of natural products and compatible with miniaturized cell based assays. J Am Chem Soc 1998; 120: 8565-66.
23. Wilkins S. High-throughput approaches to the identification and optimization of marine natural product leads. Ph.D. Dissertation, Department of Pharmacognosy, University of Mississippi 2000.
24. Pennaka HK, Yousaf M, Rao KV, Kelly M, Hill RT, Franzblau SG et al. Solving limited supplies of marine pharmaceuticals through the rational and high-throughput modification of high-yielding marine natural product scaffolds. Mar Biotechnol 2004; 6: S273-80.
25. Henkel T, Brunne RM, Muller H, Reichel F. Statistical investigation into the structural complimentarity of natural products and synthetic compounds. Angew Chem Int Edit 1999; 38: 643-47.
26. Rang HP, Dale MM, Ritter JM, Gardner R. In: Pharmacology (3rd Ed.) Antimycobacterial agents. New York, Churchill Livingstone. 1995; 738-43.
27. Kasanah N, Rao KV, Yousaf M, Wedge DE, Hill RT, Hamann MT. Biotransformation studies of the manzamine alkaloids. Mar Biotechnol 2004; 6: S268-72.
28. Clark AM, McChesney JD, Hufford CD. The use of microorganisms for the study of drug metabolism. Med Res Rev 1985; 5: 231-53.
29. Holland HL. Microbial transformations. Curr Opin Chem Biol 1998; 2(1): 77-84.
30. Riva S. Biocatalytic modification of natural products. Curr Opin Chem Biol 2001; 5: 106-11.
31. El Sayed KA, Mayer AMS, Kelly M, Hamann MT. The biocatalytic transformation of furan to amide in the bioactive marine natural product palinurin. J Org Chem 1999; 64: 9258-60.
32. El Sayed KA, Hamann MT, Waddling CA, Jensen C, Lee SK, Dunstan CA, et al. Structurally novel bioconversion products of the marine natural product sarcophine effectively inhibit JB6 cell transformation. J Org Chem 1998; 63: 7449-55.
33. Kasanah N, Yousaf M, Rao KV, Wedge DE, Hamann MT. The biocatalytic conversion of 8-hydroxymanzemine A to manzamine A. Tetrahedron Lett 2002; 44: 1291-93.
34. Sakai R, Higa T, Jefford CW, Bernardinelli G. Manzamine A, a novel antitumor alkaloid from a sponge. J Am Chem Soc 1986; 108: 6404-05.
35. Baldwin JE, Whitehead RC. On the biosynthesis of the manzamines. Tetrahedron Lett 1992; 33(15): 2059-62.
36. Tsuda M, Kobayashi J. Structures and biogenesis of manzamines and related alkaloids. Heterocycles 1997; 46: 765-94.
37. Magnier E, Langlois Y. Manzamine alkaloids, syntheses and synthetic approaches. Tetrahedron 1998; 54: 6201-58.
38. Rogers DJ, Randolph SE. The global spread of malaria in a future, warmer world. Science 2000; 289: 1763-66.
39. El Sayed KA, Kelly M, Kara UAK, Ang KKH, Hamann MT. New manzamine alkaloids with potent activity against infectious diseases. J Am Chem Soc 2001; 123: 1804-08.
40. Jones PB, Parrish NM, Houston TA, Stapon A, Niharika PB, Dick JD, et al. A new class of antituberculosis agents. J Med Chem 2000; 43: 3304-14.
41. Khan AA, Slifer T, Araujo FG, Remington JS. Trovafloxacin is active against Toxoplasma gondii. Antimicrob Agents Chemo 1996; 40: 1855-59.
42. Rao KV, Kasanah N, Wahyuono S, Tekwani BL, Schinazi RF, Hamann MT. New manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases. J Nat Prod 2003; 67: 1314-18.
43. Rao KV, Santarsiero BD, Mesecar AD, Schinazi RF, Tekwani BL, Hamann MT. New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge. J Nat Prod 2003; 66: 823-28.
44. Yousaf M, Hammond NL, Peng J, Wahyuono S, McIntosh KA, Charman WN, et al. New manzamine alkaloids from an Indo-Pacific sponge; pharmacokinetics, oral availability and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections and inflammatory diseases. J Med Chem 2004; 47: 3512-17.
45. Peng J, Hu JF, Kazi AB, Li Z, Avery M, Peraud O, et al. Manado-manzamines A and B, a novel alkaloid ring system with potent activity against mycobacteria and HIV-1. J Am Chem Soc 2003; 125: 13382-86.
46. Ohtani II, Ichiba T, Isobe M, Kelly-Borges M, Scheuer PJ. Kauluamine, an unprecedented manzamine dimer from an Indonesian marine sponge, Prianos sp. J Am Chem Soc 1995; 117: 10743-44.
47. Ang KKH, Michael JH, Higa T, Hamann MT, Kara UAK. In vivo antimalarial activity of the beta-carboline alkaloid manzamine A. Antimicrob Agents Chem 2000; 44: 1645-49.
48. Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period of 1981-2002. J Nat Prod 2003; 66: 1022-37.
49. Cortes-Selva F, Jimenez IA, Munoz-Martinez F, Campillo M, Bazzocchi IL, Pardo L, et al. Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania. Curr Pharm Des 2005; 11(24): 3125-39.
50. Rodriguez-Concepcion M. The MEP pathway: a new target for the development of herbicides, antibiotics and antimalarial drugs. Curr Pharm Des 2004; 10(19): 2391-400.
51. Seeber F, Aliverti A, Zanetti G. The plant-type ferredoxin-NADP+ reductase/ferredoxin redox system as a possible drug target against apicomplexan human parasites. Curr Pharm Des 2005; 11(24): 3159-72.